The University of Chicago Header Logo

Connection

Raghu Mirmira to Diabetes Mellitus, Type 1

This is a "connection" page, showing publications Raghu Mirmira has written about Diabetes Mellitus, Type 1.
Connection Strength

7.177
  1. Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes. Diabetes Obes Metab. 2020 10; 22(10):1827-1836.
    View in: PubMed
    Score: 0.495
  2. Hypusinated eIF5A is expressed in the pancreas and spleen of individuals with type 1 and type 2 diabetes. PLoS One. 2020; 15(3):e0230627.
    View in: PubMed
    Score: 0.485
  3. Distinct gene expression pathways in islets from individuals with short- and long-duration type 1 diabetes. Diabetes Obes Metab. 2018 08; 20(8):1859-1867.
    View in: PubMed
    Score: 0.424
  4. Inhibition of 12/15-Lipoxygenase Protects Against ß-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes. Diabetes. 2017 11; 66(11):2875-2887.
    View in: PubMed
    Score: 0.406
  5. Biomarkers of ß-Cell Stress and Death in Type 1 Diabetes. Curr Diab Rep. 2016 10; 16(10):95.
    View in: PubMed
    Score: 0.382
  6. Elevations in Circulating Methylated and Unmethylated Preproinsulin DNA in New-Onset Type 1 Diabetes. Diabetes. 2015 Nov; 64(11):3867-72.
    View in: PubMed
    Score: 0.351
  7. From immunobiology to ß-cell biology: the changing perspective on type 1 diabetes. Islets. 2014; 6(2):e28778.
    View in: PubMed
    Score: 0.315
  8. Deoxyhypusine synthase promotes differentiation and proliferation of T helper type 1 (Th1) cells in autoimmune diabetes. J Biol Chem. 2013 Dec 20; 288(51):36226-35.
    View in: PubMed
    Score: 0.312
  9. Protective effects of polyamine depletion in mouse models of type 1 diabetes: implications for therapy. Amino Acids. 2014 Mar; 46(3):633-42.
    View in: PubMed
    Score: 0.305
  10. Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes. Clin Exp Immunol. 2013 Jun; 172(3):375-82.
    View in: PubMed
    Score: 0.303
  11. Targeting regulatory T cells in the treatment of type 1 diabetes mellitus. Curr Mol Med. 2012 Dec; 12(10):1261-72.
    View in: PubMed
    Score: 0.293
  12. Islet ß-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes. 2012 Apr; 61(4):818-27.
    View in: PubMed
    Score: 0.279
  13. Development of insulin-producing cells from primitive biologic precursors. Curr Opin Organ Transplant. 2009 Feb; 14(1):56-63.
    View in: PubMed
    Score: 0.224
  14. The demise of islet allotransplantation in the United States: A call for an urgent regulatory update. Am J Transplant. 2021 04; 21(4):1365-1375.
    View in: PubMed
    Score: 0.129
  15. The role of beta-cell dysfunction in early type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2020 08; 27(4):215-224.
    View in: PubMed
    Score: 0.124
  16. Oligomeric collagen as an encapsulation material for islet/ß-cell replacement: effect of islet source, dose, implant site, and administration format. Am J Physiol Endocrinol Metab. 2020 08 01; 319(2):E388-E400.
    View in: PubMed
    Score: 0.123
  17. Comprehensive Proteomics Analysis of Stressed Human Islets Identifies GDF15 as a Target for Type 1 Diabetes Intervention. Cell Metab. 2020 02 04; 31(2):363-374.e6.
    View in: PubMed
    Score: 0.120
  18. Profiling of RNAs from Human Islet-Derived Exosomes in a Model of Type 1 Diabetes. Int J Mol Sci. 2019 11 25; 20(23).
    View in: PubMed
    Score: 0.119
  19. Abnormalities in proinsulin processing in islets from individuals with longstanding T1D. Transl Res. 2019 11; 213:90-99.
    View in: PubMed
    Score: 0.116
  20. The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes. Expert Rev Proteomics. 2019 07; 16(7):569-582.
    View in: PubMed
    Score: 0.115
  21. Response to Comment on Sims et al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258-264. Diabetes Care. 2019 05; 42(5):e85-e86.
    View in: PubMed
    Score: 0.114
  22. Combined Analysis of GAD65, miR-375, and Unmethylated Insulin DNA Following Islet Transplantation in Patients With T1D. J Clin Endocrinol Metab. 2019 02 01; 104(2):451-460.
    View in: PubMed
    Score: 0.112
  23. Analysis of serum Hsp90 as a potential biomarker of ß cell autoimmunity in type 1 diabetes. PLoS One. 2019; 14(1):e0208456.
    View in: PubMed
    Score: 0.112
  24. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care. 2019 02; 42(2):258-264.
    View in: PubMed
    Score: 0.111
  25. Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications. Pharmacol Ther. 2019 03; 195:100-110.
    View in: PubMed
    Score: 0.110
  26. Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes. Diabetes Obes Metab. 2019 01; 21(1):95-102.
    View in: PubMed
    Score: 0.109
  27. Biomarkers of islet beta cell stress and death in type 1 diabetes. Diabetologia. 2018 11; 61(11):2259-2265.
    View in: PubMed
    Score: 0.109
  28. In situ type I oligomeric collagen macroencapsulation promotes islet longevity and function in vitro and in vivo. Am J Physiol Endocrinol Metab. 2018 10 01; 315(4):E650-E661.
    View in: PubMed
    Score: 0.107
  29. Elevated unmethylated and methylated insulin DNA are unique markers of A+ß+ ketosis prone diabetes. J Diabetes Complications. 2018 02; 32(2):193-195.
    View in: PubMed
    Score: 0.103
  30. Comparative quantitative proteomic analysis of disease stratified laser captured microdissected human islets identifies proteins and pathways potentially related to type 1 diabetes. PLoS One. 2017; 12(9):e0183908.
    View in: PubMed
    Score: 0.102
  31. Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes. Diabetes Care. 2016 Sep; 39(9):1519-26.
    View in: PubMed
    Score: 0.094
  32. Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes. Transl Res. 2016 Feb; 168:96-106.e1.
    View in: PubMed
    Score: 0.089
  33. Leukotriene B4-mediated sterile inflammation promotes susceptibility to sepsis in a mouse model of type 1 diabetes. Sci Signal. 2015 Jan 27; 8(361):ra10.
    View in: PubMed
    Score: 0.085
  34. Maintenance of Pdx1 mRNA translation in islet ß-cells during the unfolded protein response. Mol Endocrinol. 2014 Nov; 28(11):1820-30.
    View in: PubMed
    Score: 0.083
  35. Eukaryotic translation initiation factor 5A inhibition alters physiopathology and immune responses in a "humanized" transgenic mouse model of type 1 diabetes. Am J Physiol Endocrinol Metab. 2014 Apr 01; 306(7):E791-8.
    View in: PubMed
    Score: 0.079
  36. Detection of islet ß-cell death in vivo by multiplex PCR analysis of differentially methylated DNA. Endocrinology. 2013 Sep; 154(9):3476-81.
    View in: PubMed
    Score: 0.076
  37. Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development. PLoS One. 2013; 8(2):e56763.
    View in: PubMed
    Score: 0.074
  38. eIF5A inhibition influences T cell dynamics in the pancreatic microenvironment of the humanized mouse model of Type 1 Diabetes. Sci Rep. 2019 02 07; 9(1):1533.
    View in: PubMed
    Score: 0.028
  39. IFN-a induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells. Diabetologia. 2018 03; 61(3):636-640.
    View in: PubMed
    Score: 0.026
  40. Mouse and human islets survive and function after coating by biosilicification. Am J Physiol Endocrinol Metab. 2013 Nov 15; 305(10):E1230-40.
    View in: PubMed
    Score: 0.019
  41. Regenerative medicine and tissue engineering: contribution of stem cells in organ transplantation. Curr Opin Organ Transplant. 2009 Feb; 14(1):46-50.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.